In case you missed it: August 23 to August 27
It was a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
FDA grants full approval to COVID vaccine
On Aug. 23, the U.S. Food and Drug Administration granted full approval to the Pfizer-BioNTech coronavirus vaccine, which is a significant milestone in the pandemic. It is the first licensing of a vaccine for the novel coronavirus.
Sexual and reproductive health services from community pharmacists
The role of the community pharmacist has greatly expanded beyond traditional product-focused services to encompass a number of sexual and reproductive health (SRH) services, according to a review in BMJ Open.
System approved for highly automated cervical cancer screening
A high-throughput molecular diagnostic system that is fully automated has won approval from the U.S. Food and Drug Administration and now is available in the U.S. market for cervical cancer screenings.
Alcohol and tobacco use during pregnancy linked to stillbirth
Alcohol and tobacco use throughout the first trimester of pregnancy was associated with nearly 3 times the risk of late stillbirth (at 28 or more weeks), compared to women who neither drank alcohol nor smoked during pregnancy or quit both before the end of the first trimester.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More
